Fibrinolysis for patients with intermediate-risk pulmonary embolism.

Meyer, Guy

Fibrinolysis for patients with intermediate-risk pulmonary embolism. [electronic resource] - The New England journal of medicine Apr 2014 - 1402-11 p. digital

Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1533-4406

10.1056/NEJMoa1302097 doi


Age Factors
Aged
Aged, 80 and over
Double-Blind Method
Drug Therapy, Combination
Female
Fibrinolytic Agents--adverse effects
Hemorrhage--chemically induced
Heparin--adverse effects
Humans
Male
Middle Aged
Pulmonary Embolism--complications
Risk Factors
Stroke--chemically induced
Tenecteplase
Tissue Plasminogen Activator--adverse effects
Treatment Outcome
Troponin--blood
Ventricular Dysfunction, Right--etiology